Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

BACKGROUND: Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requiring intensive glycemic control. This study aimed to evaluate comparative effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zi-Yang, Yang, Chun-Ting, Lin, Wei-Hung, Yao, Wen-Yu, Ou, Huang-Tz, Kuo, Shihchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552437/
https://www.ncbi.nlm.nih.gov/pubmed/37794465
http://dx.doi.org/10.1186/s12933-023-01991-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552437/
https://www.ncbi.nlm.nih.gov/pubmed/37794465
http://dx.doi.org/10.1186/s12933-023-01991-5

Ejemplares similares